Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342440 · ClinicalTrials.gov registry record
Early Detection of Advanced Adenomas and Colorectal Cancer
A clinical trial of Colorectal Cancer and Colorectal Neoplasms, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 6
- Study locations
NCT06342440 is a study of Colorectal Cancer and Colorectal Neoplasms that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 2,000 participants, above the 1,506-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (33% higher). The trial reports 6 study locations across 2 states.
The verdict
NCT06342440, a study of Colorectal Cancer and Colorectal Neoplasms, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST DENEB
Study Locations (6)
Other
- The First Affiliated Hospital of Dalian Medical University - Dalian
- IRCCS San Raffaele - Milan
- Mie University - Mie
- Barcelona University - Barcelona
California
- City of Hope Medical Center - Monrovia
- University of California San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2020-03-15 |
| Est. Completion | 2026-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06342440
The ClinicalTrials.gov registry entry for NCT06342440 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,506-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (33% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which DENEB is the first listed.
NCT06342440 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Other, California.
Frequently Asked Questions
What is clinical trial NCT06342440 about?
NCT06342440 is a clinical study titled "Early Detection of Advanced Adenomas and Colorectal Cancer". This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.
What is the current status of trial NCT06342440?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2020-03-15. Estimated completion is 2026-06-18.
What conditions does trial NCT06342440 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Disorders, Colorectal Cancer Stage II.
What interventions are being tested in trial NCT06342440?
The interventions under investigation include: DENEB (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06342440?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342440 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.